Henk Doude van Troostwijk
Corporate Officer/Principal en HANSA BIOPHARMA AB .
Cargos activos de Henk Doude van Troostwijk
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| HANSA BIOPHARMA AB | Corporate Officer/Principal | 01/06/2019 | - |
Historial de carrera de Henk Doude van Troostwijk
Antiguos cargos conocidos de Henk Doude van Troostwijk.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Raptor Pharmaceuticals Corp.
 Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | Corporate Officer/Principal | - | - |
Genzyme Europe BV
 Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The company is based in Amsterdam, Netherlands. | Corporate Officer/Principal | - | - |
| RAPTOR PHARMACEUTICAL CORP | Corporate Officer/Principal | 15/04/2012 | - |
Formación de Henk Doude van Troostwijk.
| Henley Management College | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 3 |
| Suecia | 2 |
| Reino Unido | 2 |
Operativa
| Corporate Officer/Principal | 4 |
| Masters Business Admin | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| HANSA BIOPHARMA AB | Health Technology |
| Empresas privadas | 3 |
|---|---|
Horizon Pharmaceutical LLC
 Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Horizon Pharmaceutical LLC engages in the development of transformative treatments for people affected by rare and debilitating diseases. It offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults and for six years and older children. The company was founded by Christopher M. Starr and Todd C. Zankel on April 29, 2002 and is headquartered in Novato, CA. | Health Technology |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | Health Technology |
Genzyme Europe BV
Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The company is based in Amsterdam, Netherlands. | Health Technology |
